Comment discusses the effects of missed doses on pharmacokinetics in GLP-1 therapies, suggesting significant implications for treatment adherence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: